학술논문
Two of a kind: mass and molar immunoassay-based lipoprotein (a) concentrations are similarly prognostic for MACE risk and predictive of alirocumab benefit in ODYSSEY OUTCOMES
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15229645